(Q48588616)

13 February 2018

title

Effect of the treatment period with erythromycin on cytochrome P450 3A activity in humans (English)

1 reference

13 February 2018

1 reference

Toshiaki Okudaira

1

1 reference

13 February 2018

Tsutomu Kotegawa

2

1 reference

13 February 2018

Hiromitsu Imai

3

1 reference

13 February 2018

Kimiko Tsutsumi

4

1 reference

13 February 2018

Shigeyuki Nakano

5

1 reference

13 February 2018

Kyoichi Ohashi

6

1 reference

13 February 2018

publication date

1 July 2007

1 reference

13 February 2018

The Journal of Clinical Pharmacology

published in

1 reference

13 February 2018

volume

47

1 reference

13 February 2018

issue

7

1 reference

13 February 2018

page(s)

871-876

1 reference

13 February 2018

A potentially hazardous interaction between erythromycin and midazolam.

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0091270007302562

Cytochrome P450 metabolic intermediate complexes from macrolide antibiotics and related compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007302562

Mechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007302562

The interaction of saquinavir (soft gelatin capsule) with ketoconazole, erythromycin and rifampicin: comparison of the effect in healthy volunteers and in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007302562

Dose dependent pharmacokinetics of midazolam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007302562

In-vivo kinetics of the interaction between midazolam and erythromycin in rats, taking account of metabolic intermediate complex formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007302562

Inhibition of alfentanil metabolism by erythromycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007302562

Differentiation of intestinal and hepatic cytochrome P450 3A activity with use of midazolam as an in vivo probe: effect of ketoconazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007302562

Differential mechanism-based inhibition of CYP3A4 and CYP3A5 by verapamil

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007302562

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007302562

21 January 2018

Identifiers

DOI

10.1177/0091270007302562

1 reference

13 February 2018

1 reference

13 February 2018